EGLN3 and Hyperglycemia: Our data show that salidroside could specifically suppress skeletal muscle cells PHD3 induced by hyperglycemia, and enhance the expression and secretion of VEGF-A and PDGF-BB, which are essential for promoting both the migration and proliferation potentials of endothelial and smooth muscle cells [26–29].